Gain new insights on the benefits of hubs in this feature article in Pharmaceutical Commerce, “Today's hub blueprint: Lock in on the journey,” with contributions from Conduent GM Tom Dmochowski.
Other content in this Stream
There is a growing demand in pharma for solutions that offer a data-driven approach to engage with healthcare providers in a scalable way. The end goal is to create a better end-to-end experience.
For pharma to thrive, it must adapt to using technologies like text messages, emails and IVR in thoughtful new ways to automate and to simplify the approach to patient engagement.
It’s time for the pharmaceutical services industry to start widely applying predictive analytics — and introduce prescriptive analytics — to realize the significant benefits of improved adherence.
The pandemic permanently altered the pharmaceutical industry and required novel approaches to healthcare provider and patient engagement. Here are some ways that pharma sales will continue to evolve,
Pharmaceutical manufacturers and payers are often at odds over pricing and barriers to new medication access. Payers will typically initiate a variety of cost containment initiatives,
Big data has the ability to transform pharma field sales — if pharma manufacturers can translate data into actionable insights and real-time outreach at the individual territory level.
The FDA is encouraging the industry to include patients in a meaningful way in drug development — from pre-IND through commercialization.